Evan L. Siegel
Evan L. Siegel publishes mostly in Rheumatology, Immunology and Hematology, on topics such as Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis and Rheumatoid Arthritis Research and Therapies.
- World rank
- #785,932 of 7,710,434 ranked researchers
- Rank in United States
- #262,756 of 1,627,098
- Works
- 34
- Citations
- 3.8k
- Citations per work
- 111.9
What does Evan L. Siegel research?
Evan L. Siegel's work is mostly in Medicine (55%), Immunology and Microbiology (26%), Economics, Econometrics and Finance (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1955.5%
- Medicine1955.5%
- Life Sciences925.7%
- Everything else513.8%
- Social Sciences13.0%
- Physical Sciences12.0%
- Engineering12.0%
- 1Rheumatology48% of their works
- 2Immunology26% of their works
- 3Hematology5% of their works
- 4Economics and Econometrics3% of their works
- 5Epidemiology3% of their works
- 6Civil and Structural Engineering2% of their works
Research topics
- Spondyloarthritis Studies and Treatments
- Psoriasis: Treatment and Pathogenesis
- Rheumatoid Arthritis Research and Therapies
- Autoimmune and Inflammatory Disorders Research
- Adipokines, Inflammation, and Metabolic Diseases
- Pharmaceutical Economics and Policy
- Irrigation Practices and Water Management
- Biosimilars and Bioanalytical Methods
Which keywords describe Evan L. Siegel's research?
The keywords of their largest research topics: Ankylosing Spondylitis, Spondyloarthritis, IL-17, TH17 Cells, Inflammation, Biological Therapy, Rheumatoid Arthritis and Hemophagocytic Lymphohistiocytosis.
- Immunogenicity
- Biosimilars
- Generic Drugs
- Adipose Tissue
- Hemophagocytic Lymphohistiocytosis
- Biological Therapy
- TH17 Cells
- Spondyloarthritis
- Ankylosing Spondylitis
- IL-17
- Inflammation
- Rheumatoid Arthritis
- Juvenile Idiopathic Arthritis
- Drug Development Costs
- Obesity
- Deficit Irrigation
- Water Use Efficiency
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Ankylosing Spondylitis271 topic
- Spondyloarthritis271 topic
- IL-17251 topic
- TH17 Cells251 topic
- Inflammation232 topics
- Biological Therapy211 topic
- Rheumatoid Arthritis211 topic
- Hemophagocytic Lymphohistiocytosis51 topic
- Juvenile Idiopathic Arthritis51 topic
- Adipose Tissue21 topic
- Drug Development Costs21 topic
- Generic Drugs21 topic
- Obesity21 topic
- Biosimilars11 topic
- Deficit Irrigation11 topic
- Immunogenicity11 topic
- Water Use Efficiency11 topic
Where does Evan L. Siegel work?
Evan L. Siegel's main affiliation in the publication record is Arthritis and Rheumatism Associates, United States.
How many publications and citations does Evan L. Siegel have?
OpenAlex counts 34 works and 3,806 citations for Evan L. Siegel, an h-index of 18, ranking #785,932 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Evan L. Siegel. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.